Search - tctmd.com

Displaying 101 - 120 of 730

Sort: Relevancy | Date

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

November 02, 2023

TCT 346: Impact of the Early COVID-19 Pandemic on Aortic Valve Replacement and Outcomes in France

Presentation TCT 2023

TCT 346: Impact of the Early COVID-19 Pandemic on Aortic Valve Replacement and Outcomes in France

Presenter: Graeme Prosperi-Porta

October 26, 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

TCT 385: Ten-Year Review of a Rapid Access Chest Pain Clinic: Efficiency, Cost-effectiveness, and Adaptation to the COVID-19 Pandemic

Presentation TCT 2023

TCT 385: Ten-Year Review of a Rapid Access Chest Pain Clinic: Efficiency, Cost-effectiveness, and Adaptation to the COVID-19 Pandemic

Presenter: Marwan Shawki

October 24, 2023

US Cardiologists’ Pay, Productivity Held Steady in 2022: MedAxiom Survey

News Daily News

US Cardiologists’ Pay, Productivity Held Steady in 2022: MedAxiom Survey

October 16, 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

Small Study Hints at Mechanism for COVID-Related MI and Stroke

News Daily News

Small Study Hints at Mechanism for COVID-Related MI and Stroke

October 02, 2023

Home-Based Care: ACC Workbook Aims to Inspire

News Daily News

Home-Based Care: ACC Workbook Aims to Inspire

October 02, 2023

Cardiology Orgs Unite to Create New, Independent Medical Board

News Daily News

Cardiology Orgs Unite to Create New, Independent Medical Board

Michael O'Riordan

September 21, 2023

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 12, 2023

AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP

News Daily News

AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP

September 07, 2023

Hospital at Home Strategy Could Disrupt ‘Low-Value’ Care for Worsening HF

News Daily News

Hospital at Home Strategy Could Disrupt ‘Low-Value’ Care for Worsening HF

September 07, 2023

ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD

News Conference News ESC 2023

ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD

Michael O'Riordan

September 05, 2023

Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist

News Conference News ESC 2023

Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist

August 27, 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

Upgrading to CRT Has Big Impact on HFrEF Patients With High RV Pacing Burden

News Conference News ESC 2023

Upgrading to CRT Has Big Impact on HFrEF Patients With High RV Pacing Burden

August 26, 2023

E-Cigarette Use on the Rise in US Adults With CVD

News Daily News

E-Cigarette Use on the Rise in US Adults With CVD

August 16, 2023

What’s Going to Be Hot at ESC 2023?

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

August 15, 2023

SCAI Joins the Fray as ABIM’s MOC Program Pushback Mounts

News Daily News

SCAI Joins the Fray as ABIM’s MOC Program Pushback Mounts

August 11, 2023

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

News Daily News

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

August 09, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.